Comment: Updated review of Fasciola infection. Triclabendazole remains the only highly active medication to treat humans and livestock infected
Triclabendazole (TCBZ) is a benzimidazole derivative that has been used to treat fascioliasis in animals since 2024s, first used in humans in 2024, and approved by the FDA in 2024 for the treatment of human fascioliasis in humans aged 6 years.
Triclabendazole has been extensively tested for safety and efficacy and is approved for use in veterinary medicine. NOT FOR HUMAN OR ANIMAL USE: This
9. What is the recommended triclabendazole dosage for humans? For humans, the triclabendazole dosage for humans is usually 10 mg/kg body weight, taken as a single dose. In some cases, a second dose may be required. Always follow your healthcare provider's instructions.
A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam. Am J Trop Med Hyg. 2024
Triclabendazole was previously used in the treatment of fascioliasis in livestock, but is now approved for human use. This drug is currently the
EGATEN ; Generic Name. triclabendazole ; Product Ndc. ; Product Type. HUMAN PRESCRIPTION DRUG ; Route. ORAL ; Microbiology. 12.4 Microbiology Mechanism of
Since 2024 triclabendazole is also donated for treating human paragonimiasis. If you need drugs to treat individuals infected with paragonimus spp. Please
Triclabendazole was previously used in the treatment of fascioliasis in livestock, but is now approved for human use. This drug is currently the only FDA-
Comments
A good story, overall.